Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Targeted Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Temporarily pausedNCT06792344
What this trial is testing

Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis

Who this might be right for
Systemic Sclerosis (SSc)
The Children's Hospital of Zhejiang University School of Medicine 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439175
What this trial is testing

Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 70
Not applicableNot Yet RecruitingNCT07388030
What this trial is testing

Lithotripsy Versus Balloon Angioplasty for Optimal Treatment of CAlcified Lesions With and Without Optical Coherence Tomography evaluatION

Who this might be right for
Coronary Artery DiseaseSevere Coronary Artery DiseaseCoronary Artery Calcification
Shanghai Bluesail Boyuan Medical Technology Co., Ltd. 3,060
Testing effectiveness (Phase 2)Looking for participantsNCT06897930
What this trial is testing

Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Who this might be right for
Lupus Erythematosus, Systemic
AstraZeneca 150
Not applicableActive Not RecruitingNCT04541030
What this trial is testing

Integrated Genomic Prostate Score With MRI Targeted Prostate Biopsies

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 241
Not applicableUnknownNCT02458664
What this trial is testing

BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer

Who this might be right for
Rectum CancerCancer of Colon
Assistance Publique - Hôpitaux de Paris 597
Not applicableNot Yet RecruitingNCT06464601
What this trial is testing

A Real-World Study of Neoadjuvant/Conversion Therapy for Locally Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Wuhan University 70
Not applicableStudy completedNCT02087930
What this trial is testing

Microbiota as Potential Target for Food Allergy

Who this might be right for
Cow Milk Allergy
Federico II University 600
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07569965
What this trial is testing

Frontline Risk-Adapted Optimization of Novel Targeted Immunotherapy Evaluation in High-Risk MCL

Who this might be right for
Mantle Cell Lymphoma (MCL)
Miltenyi Biomedicine GmbH 52
Not applicableUnknownNCT04109300
What this trial is testing

Preemptive HLA Genotyping for the Safe Use of Infliximab-combination Therapy in Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease
Western University, Canada 162
Early research (Phase 1)Looking for participantsNCT07621692
What this trial is testing

Exploring Auger-Enhanced PSMA-Targeted Radioligand Therapy: A First-in-Taiwan Clinical Study of 161Tb-PSMA-I&T

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
National Taiwan University Hospital 12
Testing effectiveness (Phase 2)UnknownNCT05225844
What this trial is testing

An Exploratory Trail of Camrelizumab Plus Apatinib Mesylate for Advanced Gastrointestinal

Who this might be right for
Gastrointestinal CancerImmunotherapyTargeted Therapy
Harbin Medical University 150
Not applicableNot Yet RecruitingNCT05909137
What this trial is testing

Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer

Who this might be right for
ImmunotherapyIntensity Modulated Radiation TherapyRadiotherapy+1 more
Xinqiao Hospital of Chongqing 60
Early research (Phase 1)Active Not RecruitingNCT06147037
What this trial is testing

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorMetastatic Colorectal CarcinomaHead and Neck Squamous Cell Carcinoma+4 more
AstraZeneca 13
Not applicableUnknownNCT03009565
What this trial is testing

Does the Human Gut Microbiome Serve as a Novel Personalized Therapeutic Target for Coronary Atherosclerosis?

Who this might be right for
Coronary (Artery) Disease
Rabin Medical Center 800
Testing effectiveness (Phase 2)Looking for participantsNCT04116541
What this trial is testing

A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.

Who this might be right for
Malignant Solid Tumor
Centre Leon Berard 455
Testing effectiveness (Phase 2)Study completedNCT01442129
What this trial is testing

The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in Patients Undergoing LVAD Implantation

Who this might be right for
Heart FailureCardiomyopathyVentricular Dysfunction
Deborah Ascheim 30
Not applicableNot Yet RecruitingNCT07767877
What this trial is testing

Clinical Practice and Real-world Care of Patients Treated With mTOR, PI3K, and MEK Inhibitors for Extracranial Vascular Anomalies

Who this might be right for
Vascular Anomalies
Novartis Pharmaceuticals 200
Testing effectiveness (Phase 2)Study completedNCT01882829
What this trial is testing

Nuedexta in Treatment-Resistant Major Depression

Who this might be right for
Major Depressive DisorderTreatment Resistant
James Murrough 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04620239
What this trial is testing

ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

Who this might be right for
Transitional Cell Cancer of Renal Pelvis and Ureter
Steba Biotech S.A. 89
Next Page